171 related articles for article (PubMed ID: 33019728)
1. The Relationship between Leptin, the Leptin Receptor and FGFR1 in Primary Human Breast Tumors.
Boothby-Shoemaker W; Benham V; Paithankar S; Shankar R; Chen B; Bernard JJ
Cells; 2020 Oct; 9(10):. PubMed ID: 33019728
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
[TBL] [Abstract][Full Text] [Related]
3. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
[TBL] [Abstract][Full Text] [Related]
4. Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells.
Chi F; Griffiths JI; Nath A; Bild AH
Breast Cancer Res; 2024 Mar; 26(1):54. PubMed ID: 38553760
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular crosstalk between leptin receptor and estrogen receptor-{alpha} in breast cancer: molecular basis for a novel therapeutic setting.
Fusco R; Galgani M; Procaccini C; Franco R; Pirozzi G; Fucci L; Laccetti P; Matarese G
Endocr Relat Cancer; 2010 Jun; 17(2):373-82. PubMed ID: 20410173
[TBL] [Abstract][Full Text] [Related]
6. Low prognostic implication of fibroblast growth factor family activation in triple-negative breast cancer subsets.
Lee HJ; Seo AN; Park SY; Kim JY; Park JY; Yu JH; Ahn JH; Gong G
Ann Surg Oncol; 2014 May; 21(5):1561-8. PubMed ID: 24385208
[TBL] [Abstract][Full Text] [Related]
7. The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?
Massabeau C; Sigal-Zafrani B; Belin L; Savignoni A; Richardson M; Kirova YM; Cohen-Jonathan-Moyal E; Mégnin-Chanet F; Hall J; Fourquet A
Breast Cancer Res Treat; 2012 Jul; 134(1):259-66. PubMed ID: 22438050
[TBL] [Abstract][Full Text] [Related]
8. Leptin and its receptor are overexpressed in breast cancer tissue of postmenopausal Mexican-Mestizo women with obesity.
Cárdenas Cárdenas E; Tenorio-Torres A; Méndez JP; Orozco-Arguelles L; Leal-García M; Coral-Vázquez RM; Vega-García CC; Bautista-Piña V; Canto P
Ann Diagn Pathol; 2022 Oct; 60():151705. PubMed ID: 33685748
[TBL] [Abstract][Full Text] [Related]
9. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
[TBL] [Abstract][Full Text] [Related]
10. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
[No Abstract] [Full Text] [Related]
11. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
Wellberg EA; Kabos P; Gillen AE; Jacobsen BM; Brechbuhl HM; Johnson SJ; Rudolph MC; Edgerton SM; Thor AD; Anderson SM; Elias A; Zhou XK; Iyengar NM; Morrow M; Falcone DJ; El-Hely O; Dannenberg AJ; Sartorius CA; MacLean PS
JCI Insight; 2018 Jul; 3(14):. PubMed ID: 30046001
[TBL] [Abstract][Full Text] [Related]
12. The Use of Human Serum Samples to Study Malignant Transformation: A Pilot Study.
Holowatyj AN; Gigic B; Warby CA; Ose J; Lin T; Schrotz-King P; Ulrich CM; Bernard JJ
Cells; 2021 Oct; 10(10):. PubMed ID: 34685650
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization of leptin and leptin receptor in breast cancer detected in an electron microscopic study.
Al-Shibli SM; Amjad NM; Al-Kubaisi MK; Mizan S
Biochem Biophys Res Commun; 2017 Jan; 482(4):1102-1106. PubMed ID: 27914811
[TBL] [Abstract][Full Text] [Related]
14. Differential roles of fibroblast growth factor receptors (FGFR) 1, 2 and 3 in the regulation of S115 breast cancer cell growth.
Tarkkonen KM; Nilsson EM; Kähkönen TE; Dey JH; Heikkilä JE; Tuomela JM; Liu Q; Hynes NE; Härkönen PL
PLoS One; 2012; 7(11):e49970. PubMed ID: 23185502
[TBL] [Abstract][Full Text] [Related]
15. FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
Turner N; Pearson A; Sharpe R; Lambros M; Geyer F; Lopez-Garcia MA; Natrajan R; Marchio C; Iorns E; Mackay A; Gillett C; Grigoriadis A; Tutt A; Reis-Filho JS; Ashworth A
Cancer Res; 2010 Mar; 70(5):2085-94. PubMed ID: 20179196
[TBL] [Abstract][Full Text] [Related]
16. TNFAIP3 is required for FGFR1 activation-promoted proliferation and tumorigenesis of premalignant DCIS.COM human mammary epithelial cells.
Yang M; Yu X; Li X; Luo B; Yang W; Lin Y; Li D; Gan Z; Xu J; He T
Breast Cancer Res; 2018 Aug; 20(1):97. PubMed ID: 30111373
[TBL] [Abstract][Full Text] [Related]
17. Greater Body Fatness Is Associated With Higher Protein Expression of LEPR in Breast Tumor Tissues: A Cross-Sectional Analysis in the Women's Circle of Health Study.
Llanos AAM; Aremu JB; Cheng TD; Chen W; Chekmareva MA; Cespedes Feliciano EM; Qin B; Lin Y; Omene C; Khoury T; Hong CC; Yao S; Ambrosone CB; Bandera EV; Demissie K
Front Endocrinol (Lausanne); 2022; 13():879164. PubMed ID: 35846306
[TBL] [Abstract][Full Text] [Related]
18. Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.
Ling L; Tan SK; Goh TH; Cheung E; Nurcombe V; van Wijnen AJ; Cool SM
Mol Cancer; 2015 Jul; 14():136. PubMed ID: 26201468
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
Tomiguchi M; Yamamoto Y; Yamamoto-Ibusuki M; Goto-Yamaguchi L; Fujiki Y; Fujiwara S; Sueta A; Hayashi M; Takeshita T; Inao T; Iwase H
Cancer Sci; 2016 Apr; 107(4):491-8. PubMed ID: 26801869
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor receptor 1 protein (FGFR1) as potential prognostic and predictive marker in patients with luminal B breast cancers overexpressing human epidermal receptor 2 protein (HER2).
Amina B; Lynda AK; Sonia S; Adel B; Jelloul BH; Miloud M; Tewfik S
Indian J Pathol Microbiol; 2021; 64(2):254-260. PubMed ID: 33851617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
